Article Information
History
- November 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Richard A. Baylis1,2,3,*,
- Fudi Wang1,2,*,
- Hua Gao1,2,
- Caitlin Bell1,2,4,
- Lingfeng Luo1,2,
- Kevin T. Nead5,6,
- Tomas G. Neilan7,
- Elsie Gyang Ross1,2,
- Derek Klarin1,2,# and
- Nicholas J. Leeper1,2,4,#
- 1Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, CA, USA
- 2Stanford Cardiovascular Institute, Stanford, CA, USA
- 3Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- 4Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 5Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, USA
- 6Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, USA
- 7Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
- ↵#Co-corresponding author Derek Klarin, MD, Department of Surgery, Division of Vascular Surgery, Biomedical Innovations Building, 240 Pasteur Drive, Palo Alto, CA 94304., dklarin{at}stanford.edu, Nicholas J. Leeper, MD, Department of Surgery, Division of Vascular Surgery Biomedical Innovations Building, 240 Pasteur Drive, Palo Alto, CA 94304., Phone: 650-724-8475, nleeper{at}stanford.edu
Posted November 08, 2022.
Coronary artery disease and prostate cancer share a common genetic risk mediated through Lipoprotein(a)
